Caxton Associates (New York)’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $1.34M | Sell |
|
|||||
|
2024
Q3 | $2.83M | Buy |
|
|||||
|
2024
Q2 | $1.75M | Sell |
|
|||||
|
2024
Q1 | $4.3M | Sell |
|
|||||
|
2023
Q4 | $4.34M | Buy |
|
|||||
|
2023
Q3 | $2.61M | Buy |
|
|||||
|
2023
Q2 | $2.32M | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $376K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $540K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $571K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $1.16M | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $273K | Sell |
|
|||||
|
2018
Q2 | $821K | Sell |
|
|||||
|
2018
Q1 | $870K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $463K | Buy |
|